Micell's supercritical fluid technology (SCF) provides several unique advantages in the modification and coating of biomedical surfaces with advanced polymers and drugs. Compared to current solvent-based coating systems, Micell's technology for creating drug-eluting coatings is:
Dry - Meaning that polymers, drugs and medical devices are not exposed to conventional liquid solvents.
Cool - Our processes function at moderate temperatures to preserve the structure and morphology of therapeutic agents.
Flexible - By combining electrostatic attraction with supercritical fluids, Micell can create surface modifications for a broad range of medical devices using a variety of polymers and drugs.
The supercritical fluid process allows the use of therapeutic agents that may be sensitive to elevated temperatures or traditional solvent processes. Most existing coating processes for medical devices involve an organic solvent that may alter the chemistry of the therapeutic agent or affect human health. Micell's SCF-based methods - which are completely solvent-free - avoid the challenges associated with the use of common solvents and offer opportunities for significant and rapid process advantages.